Pittsburgh, PA, United States of America

Robert H Bahnson

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert H Bahnson. Retrieved from https://idiyas.com/inventor/robert-h-bahnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Robert H Bahnson

Introduction

Robert H Bahnson is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of nuclear matrix proteins. His work has implications for diagnosing and treating various cell proliferative disorders.

Latest Patents

Robert H Bahnson holds a patent for "Bladder nuclear matrix proteins, polynucleotide sequences encoding them." This patent describes nuclear matrix proteins (NMP) that are characterized by a defined expression in tissue. These NMPs serve as useful markers for diagnosing and monitoring the stage of malignancy in cells. Additionally, they play a role in treating cell proliferative disorders associated with the NMP. The patent also includes substantially purified polypeptides and nucleotide sequences encoding the NMPs of the invention. He has 1 patent to his name.

Career Highlights

Robert H Bahnson is affiliated with the University of Pittsburgh, where he conducts his research. His work has been instrumental in advancing the understanding of nuclear matrix proteins and their applications in medical diagnostics and treatment.

Collaborations

Robert H Bahnson has collaborated with Robert H Getzenberg, further enhancing the research output in their field.

Conclusion

Robert H Bahnson's innovative work in nuclear matrix proteins has the potential to significantly impact the diagnosis and treatment of malignancies. His contributions to the field exemplify the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…